Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma
Sheridan L. Swan, Nalini Mehta, Ekaterina Ilich, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22

Showing 22 citing articles:

The potential and promise for clinical application of adoptive T cell therapy in cancer
Yinqi Li, Yeteng Zheng, Taiqing Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy
Colleen Foley, Sheridan L. Swan, Melody A. Swartz
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 188-198
Closed Access | Times Cited: 7
Exosome-based nanoparticles and cancer immunotherapy
Jiarong Ye, Danni Li, Yiting Jie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117296-117296
Open Access | Times Cited: 7
Advances in IL-7 Research on Tumour Therapy
Chunxue Fu, Xinqiang Zhang, Xinyu Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 415-415
Open Access | Times Cited: 6
Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update
Roa Alsajjan, Warren Mason
Current Oncology (2023) Vol. 30, Iss. 9, pp. 8501-8549
Open Access | Times Cited: 14
Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion
Jessica Waibl Polania, Alexandra Hoyt-Miggelbrink, William H. Tomaszewski, et al.
Immunity (2024)
Open Access | Times Cited: 5
Mechanisms of antigen-dependent resistance to chimeric antigen receptor (CAR)-T cell therapies
Fatemeh Nasiri, Pouya Safarzadeh Kozani, Faeze Salem, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
Bryan Gardam, Tessa Gargett, Michael P. Brown, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges
Jie Lu, Wen Huo, Yingze Ma, et al.
Cancer Letters (2024) Vol. 600, pp. 217185-217185
Open Access | Times Cited: 3
Strategies to overcome tumor microenvironment immunosuppressive effect on the functioning of CAR-T cells in high-grade glioma
Julia Zarychta, Adrian Kowalczyk, Anna Marszołek, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 3
The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma
Moloud Sooreshjani, Shashwat Tripathi, Corey Dussold, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3739-3739
Open Access | Times Cited: 8
IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models
Justin Yu, Jacob Gadwa, Richard B. Ross, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 2
From barriers to novel strategies: smarter CAR T therapy hits hard to tumors
Muhammad Babar Khawar, Fei Ge, Ali Afzal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma
Kristen D. Pawlowski, Joseph Duffy, Stephen Gottschalk, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5852-5852
Open Access | Times Cited: 6
Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
Kun Ma, Ping Hu
Cancers (2023) Vol. 15, Iss. 23, pp. 5652-5652
Open Access | Times Cited: 4
Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential
Diego F. Chamorro, Lauren K. Somes, Valentina Hoyos
Cancers (2023) Vol. 16, Iss. 1, pp. 124-124
Open Access | Times Cited: 4
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
Pin Mei Yao, Yaguang Liu, Gang Huang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Engineered Flt3L Drives Tolerogenic State to Attenuate Anti-drug Antibody Responses
Aaron T. Alpar, Rachel P. Wallace, Kirsten C. Refvik, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Engineering the Microstructure and Spatial Bioactivity of MAP Scaffolds Instructs Vasculogenesis In Vitro and Modifies Vessel Formation In Vivo
Alexa R. Anderson, Eleanor L. P. Caston, Lindsay Riley, et al.
Advanced Functional Materials (2024)
Closed Access
The Therapeutic Values of IL-7/IL-7R and the Recombinant Derivatives in Glioma: A Narrative Review
Marjan Hesari, Zeinab Attar, Shakiba Soltani-Shirazi, et al.
Journal of Interferon & Cytokine Research (2023) Vol. 43, Iss. 8, pp. 319-334
Closed Access | Times Cited: 1
Antigen presentation by tumor-associated macrophages mediates progenitor to terminal exhaustion transition in GBM and other solid tumors
Jessica Waibl Polania, Alexandra Miggelbrink, William H. Tomaszewski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Engineering the microstructure and spatial bioactivity of MAP scaffolds in vitro instructs neovascularization in vivo
Alexa R. Anderson, Eleanor L. P. Caston, Lindsay Riley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top